Qube Research & Technologies Ltd - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$754,917
-66.7%
64,578
-47.0%
0.00%
-83.3%
Q4 2022$2,266,838
+163.6%
121,873
-0.6%
0.01%
+100.0%
Q2 2022$860,000
-32.5%
122,638
-20.2%
0.01%
-45.5%
Q1 2022$1,274,000
+5.6%
153,709
-13.8%
0.01%
+22.2%
Q4 2021$1,207,000
+169.4%
178,320
+111.0%
0.01%
+50.0%
Q3 2021$448,000
+75.7%
84,502
+90.9%
0.01%
+100.0%
Q2 2021$255,000
+94.7%
44,264
+30.1%
0.00%
-40.0%
Q1 2020$131,00034,0240.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders